The elevated soluble CD163 present in SSc patient plasma may be explained by the higher levels of TNF-α converting enzyme that mediates shedding of the CD163 ectodomain [200] in PBMC of patients with early SSc [201]. This evidence concerns the gene CD163 and systemic sclerosis.